Patent · US Active

Dosed delivery of autonomic modulation therapy

US9517350B2 · kind B2 · utility

20Cited by
7References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 2, 2014
Grant dateDec 13, 2016
Priority date
Expiry dateDec 2, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/3727
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

An example of a method embodiment may include receiving a user programmable neural stimulation (NS) dose for an intermittent neural stimulation (INS) therapy, and delivering the INS therapy with the user programmable NS dose to an autonomic neural target of a patient. Delivering the INS therapy may include delivering NS bursts, and delivering the NS bursts may include delivering a number of NS pulses per cardiac cycle during a portion of the cardiac cycles and not delivering NS pulses during a remaining portion of the cardiac cycles. The method may further include sensing cardiac events within the cardiac cycles, and controlling delivery of the user programmable NS dose of INS therapy using the sensed cardiac events to time delivery of the number of NS pulses per cardiac cycle to provide the user programmable NS dose. The user programmable NS dose may determine the number of NS pulses per cardiac cycle.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.